3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer
-
Subject Areas on Research
- Activation of kappa opioid receptors by U50488H and morphine enhances the release of substance P from rat trigeminal nucleus slices.
- Car8 dorsal root ganglion expression and genetic regulation of analgesic responses are associated with a cis-eQTL in mice.
- Chronic administration of U50,488H fails to produce hypothalamo-pituitary-adrenal axis tolerance in neonatal rats.
- Early ontogeny of kappa-opioid receptor regulation of prolactin secretion in the rat.
- Effects of specific mu and kappa opiate tolerance and abstinence on hypothalamo-pituitary-adrenal axis secretion in the rat.
- Induction of bladder sphincter dyssynergia by kappa-2 opioid receptor agonists in the female rat.
- Mu- and kappa-opiate receptor control of prolactin secretion in rats: ontogeny and interaction with serotonin.
- Ontogeny of mu- and kappa-opiate receptor control of the hypothalamo-pituitary-adrenal axis in rats.
- Opioid inhibition of rapid eye movement sleep by a specific mu receptor agonist.
- Prolonged kappa opioid receptor phosphorylation mediated by G-protein receptor kinase underlies sustained analgesic tolerance.
- Regulation and function of MeCP2 Ser421 phosphorylation in U50488-induced conditioned place aversion in mice.
- Voltage-dependent effects of opioid peptides on hippocampal CA3 pyramidal neurons in vitro.
- mu-Opioid agonists stimulate growth hormone secretion in immature rats.